Pyrimidine compound
US-2026053911-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Sumitomo Pharma Co Ltd — Cross-Sectional Technologies
Sumitomo Pharma Co Ltd holds 9 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Sumitomo Pharma Co Ltd |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 9 |
| Recent patents in slice | 8 |
| First year | 2023 |
| Last year | 2026 |
Representative patents
Notable publications linking Sumitomo Pharma Co Ltd to Cross-Sectional Technologies.
Pyrimidine compound
US-2026053911-A1 · Feb 26, 2026 · US
Substituted pyrimidines as vaccine adjuvants
US-12440560-B2 · Oct 14, 2025 · US
Substituted pyrimidines as vaccine adjuvants
US-12440560-B2 · Oct 14, 2025 · US
Carboxylic acid compounds
US-12077510-B2 · Sep 3, 2024 · US
Recent filings
Latest patents from Sumitomo Pharma Co Ltd in Cross-Sectional Technologies.
Pyrimidine compound
US-2026053911-A1 · Feb 26, 2026 · US
Pyrimidine compound
US-2026053911-A1 · Feb 26, 2026 · US
Substituted pyrimidines as vaccine adjuvants
US-12440560-B2 · Oct 14, 2025 · US
Substituted pyrimidines as vaccine adjuvants
US-12440560-B2 · Oct 14, 2025 · US
Carboxylic acid compounds
US-12077510-B2 · Sep 3, 2024 · US
Related pages
Navigate to parent entity pages.